期刊文献+

抗-D免疫球蛋白治疗儿童特发性血小板减少性紫癜研究进展 被引量:7

Study Progress of Anti - D Immunoglobulin Treatment on Childhood Idiopathic Thrombocytopenic Purpura
分享 导出
摘要 抗-D免疫球蛋白的临床应用是特发性血小板减少性紫癜(ITP)的治疗方法。研究表明抗-D免疫球蛋白治疗儿童ITP有效、安全、经济、使用方便,可以替代IVIG作为一线治疗药物。2011年,美国血液病协会在以证据为基础的免疫性血小板减少症的实践指南中建议Rh阳性、脾未切除的患者使用抗一D免疫球蛋白作为一线治疗药物。现就抗-D免疫球蛋白的作用机制、治疗和不良反应进行综述。 Anti - D immunoglobulin increased the clinical application of treatment of idiopathic thrombocytopenic purpura (ITP). Studies have shown that it is effective, safe, cheap and easy to use in the treatment of childhood [TP, and can be used as first - line alternative thera- py on intravenous immune globulin. A single dose of anti - D can be used as first - line treatment in Rh - positive, nonsplenectomized children requiring treatment in the American Society of Hematology 2011 evidence- based practice guideline for immune thrombocytopenia, The mec- hanisms, treatment and side effects of anti - D immunoglobulin are summarized below.
作者 泥永安 刘壮 N1 Yong - an, LIU Zhuang ( Department of Pediatrics, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China)
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2012年第3期 221-223,共3页 Journal of Applied Clinical Pediatrics
关键词 抗-D免疫球蛋白 特发性血小板减少性紫癜 治疗 不良反应 儿童 anti - D immunoglobulin idiopathic thrombocytopenic purpura treatment side effect child i
作者简介 泥永安,男,硕士生,研究方向为血液/肿瘤疾病,电子信箱nyaboxing@163.com。 刘壮,男,主任医师,教授,博士学位,研究方向为血液/肿瘤疾病,电子信箱lznngx@163.com。
  • 相关文献

参考文献32

  • 1Chandra J,Choudhry VP.Stimulating platelet production to raise plateletcount in immune thrombocytopenic purpura:A novel approach[J].In-dian J Pediatr,2009,76(10):1065-1066. 被引量:1
  • 2Bennett CM,Tarantino M.Chronic immune thrombocytopenia in chil-dren:Epidemiology and clinical presentation[J].Hematol Oncol ClinNorth Am,2009,23(6):1223-1238. 被引量:1
  • 3金呈强,董海新,刘仿,宋丽,赵元明,孙传祥,高岩,高东田,盛蕊.急性特发性血小板减少性紫癜患儿外周血血小板相关抗体和白细胞介素18的检测[J].新乡医学院学报,2010(1):48-51. 被引量:15
  • 4金呈强,刘仿,肖红,宋丽,王文涓.急性特发性血小板减少性紫癜患儿外周血淋巴细胞过氧化物酶体增生物活化受体γmRNA表达及其与血清白细胞介素-2的相关性[J].新乡医学院学报,2009,26(1):13-15. 被引量:11
  • 5Cooper N.Intravenous immunoglobulin and anti-RhD therapy in themanagement of immune thrombocytopenia[J].Hematol Oncol Clin NorthAm,2009,23(6):1317-1327. 被引量:1
  • 6Pang SJ,Lazarus AH.Mechanisms of platelet recovery in ITP associatedwith therapy[J].Ann Hematol,2010,89(suppl 1):31-35. 被引量:1
  • 7Provan D,Stasi R,Newland AC,et al.International consensus report onthe investigation and management of primary immune thrombocytopenia[J].Blood,2010,115(2):168-186. 被引量:1
  • 8Tarantino MD,Young G,Bertolone SJ,et al.Single dose of anti-D im-mune globulin at 75 microg/kg is as effective as intravenous immuneglobulin at rapidly raising the platelet count in newly diagnosed immunethrombocytopenic purpura in children[J].J Pediatr,2006,148(4):489-494. 被引量:1
  • 9El Alfy MS,Mokhtar GM,El-Laboudy MA,et al.Randomized trial ofanti-D immunoglobulin versus low-dose intravenous immunoglobulinin the treatment of childhood chronic idiopathic thrombocytopenic purpu-ra[J].Acta Haematol,2006,115(1-2):46-52. 被引量:1
  • 10Trebo MM,Frey E,Gadner H,et al.Subcutaneous anti-D globulin ap-plication is a safe treatment option of immune thrombocytopenia in chil-dren[J].Ann Hematol,2010,89(4):415-418. 被引量:1

二级参考文献37

  • 1张军红,徐酉华.特发性血小板减少性紫癜发病机制研究进展[J].实用儿科临床杂志,2009(9):700-702. 被引量:14
  • 2陆皖珍,伊华.脾动脉栓塞治疗特发性血小板减少性紫癜的护理[J].中国临床保健杂志,2006,9(4):395-396. 被引量:3
  • 3中华医学会血液学学会血栓与止血学组.几种出血性疾病诊断(及疗效)标准的修订[J].中华血液学杂志,1995,16:331-331. 被引量:85
  • 4Canes DB,McMillan R. Management of adult idiopathic thrombocytopenic purpura[ J ]. Annu Rev Mad ,2005 ( 56 ) :425-442. 被引量:1
  • 5McMilan R . Classical management of refractory adult immune ( idiopathic ) thrombocytopenic purpura [ J ]. Blood Rev, 2002, 16( 1 ) :51-55. 被引量:1
  • 6Napimoga MH, Vieira SM, Dal-Secco D. Peroxisome proliferatoractivated receptor-γ ligand, 15-deoxy-△12, 14-Prostaglandin J2, reduces neutrophil migration via a nitric oxide pathway [ J ]. The Journal oflmmunology,2008,180( 1 ) :609-617. 被引量:1
  • 7Zhang X, Rodriguez-Galan MC, Subleski JJ. Pemxisome proliferatoractivated receptor-γ and its ligands attenuate biologic functions of human natural killer cells [ J]. Blood,2004,104 ( 10 ) :3276-3284. 被引量:1
  • 8Augstein P, Dunger A, Heinke P. Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells [ J ]. Biochem Biophys Res Commun, 2003,304 (2) :378-384. 被引量:1
  • 9Bassaganya-Riera J, Pogranichniy RM, Jobgen SC, et al. Conjugated linoleic acid ameliorates viral infectivity in a pig model of virally induced immunosuppression [ J ]. Nutr, 2003,133 ( 10 ) : 3204- 3214. 被引量:1
  • 10Wu D, Meydani SN. Age-associated changes in immune and inflammatory responses : impact of vitamin E intervention [ J ]. Biol,2008,84 (4) :563-569. 被引量:1

共引文献21

同被引文献75

  • 1梁超,陆敏秋.丙种球蛋白联合强的松治疗特发性血小板减少性紫癜的护理[J].护士进修杂志,2008(17):1580-1581. 被引量:5
  • 2李文莲,李光贵.不同剂量静脉免疫球蛋白治疗极重度ITP疗效分析[J].遵义医学院学报,2010(6):580-582. 被引量:2
  • 3Gupta V, Tilak V, Bhatia BD. Immune thrombocytopenic pur- pura [J]. Indian J Pediatr, 2008, 75(7): 723-728. 被引量:1
  • 4Blanchette V, Bolton-Maggs P. Childhood immune thrombo-cytopenic purpura., diagnosis and management [J]. Hematol Oncol Clin North Am, 2010, 24(1): 249-273. 被引量:1
  • 5Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group [J]. Blood, 2009, 113(11): 2386-2393. 被引量:1
  • 6Cooper N. Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia [J]. Hematol Oncol ClinNorth Am, 2009, 23(6): 1317-1327. 被引量:1
  • 7Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2011 evidence-based practice guideline for im- mune thrombocytopenia [J]. Blood, 2011, 117(16): 4190-4207. 被引量:1
  • 8Cheung E, Liebman HA. Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia [J]. Biologics, 2009, 3:57-62. 被引量:1
  • 9Pang SJY, Lazarus AH. Mechanisms of platelet recovery in ITP associated with therapy [J]. Ann Hematol, 2010, 89(Suppl 1): $31- $35. 被引量:1
  • 10Provan D, Stasi R, Newland AC, et al. International consen- sus report on the investigation and management of primary immune thrombocytopenia [J]. Blood, 2010, 115(2): 168-186. 被引量:1

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈